Abstract
Inherited defects of oxidative phosphorylation lead to heterogeneous, often multisystem, mitochondrial diseases. This review highlights those mitochondrial syndromes with prominent gastrointestinal and hepatic symptoms, categorised according to underlying disease mechanism. Mitochondrial encephalopathies with major gastrointestinal involvement include mitochondrial neurogastrointestinal encephalopathy and ethylmalonic encephalopathy, which are each associated with highly specific clinical and metabolic profiles. Mitochondrial hepatopathies are most frequently caused by defects of mitochondrial DNA maintenance and expression. Although mitochondrial disorders are notorious for extreme clinical, biochemical and genetic heterogeneity, there are some pathognomonic clinical and metabolic clues that suggest a specific diagnosis, and these are highlighted. An approach to diagnosis of these complex disorders is presented, together with a genetic classification, including mitochondrial DNA disorders and nuclear-encoded defects of mitochondrial DNA maintenance and translation, OXPHOS complex assembly and mitochondrial membrane lipids. Finally, supportive and experimental therapeutic options for these currently incurable diseases are reviewed, including liver transplantation, allogeneic haematopoietic stem cell transplantation and gene therapy.
Similar content being viewed by others
References
Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006) The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835–1846
Arnaudo E, Dalakas M, Shanske S, Moraes CT, Dimauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337:508–510
Bicknese AR, May W, Hickey WF, Dodson WE (1992) Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 32:767–775
Bitner-Glindzicz M, Pembrey M, Duncan A et al (2009) Prevalence of mitochondrial 1555A–>G mutation in European children. N Engl J Med 360:640–642
Chang TM, Chi CS, Tsai CR, Lee HF, Li MC (2004) Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol 31:374–377
Chrzanowska-Lightowlers ZM, Horvath R, Lightowlers RN (2011) 175th ENMC international workshop: mitochondrial protein synthesis in health and disease, 25-27th June 2010, Naarden, The Netherlands. Neuromuscul Disord 21:142–147
Coenen MJ, Antonicka H, Ugalde C et al (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080–2086
Cohen BH, Chinnery PF, Copeland WC et al (2010) POLG-Related Disorders. 2010 Mar 16 [Updated 2012 Oct 11]. In: Pagon RA, Bird TD, Dolan CR (eds) GeneReviews™ [internet]. University of Washington, Seattle, 1993-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK26471/
Cormier-Daire V, Bonnefont JP, Rustin P et al (1994) Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 124:63–70
Cormier-Daire V, Chretien D, Rustin P et al (1997) Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 130:817–822
Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol 49:377–383
de Lonlay P, Valnot I, Barrientos A et al (2001) A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 29:57–60
Debray FG, Morin C, Janvier A et al (2011) LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome c oxidase deficiency. J Med Genet 48(3):183-9
Delarue A, Paut O, Guys JM et al (2000) Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant 4:67–71
Di Meo I, Auricchio A, Lamperti C, Burlina A, Viscomi C, Zeviani M (2012) Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy. EMBO Mol Med 4:1008–1014
Dimmock DP, Dunn JK, Feigenbaum A et al (2008a) Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl 14:1480–1485
Dimmock DP, Zhang Q, Dionisi-Vici C et al (2008b) Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 29:330–331
Dubern B, Broue P, Dubuisson C et al (2001) Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation 71:633–637
El-Hattab AW, Li FY, Schmitt E, Zhang S, Craigen WJ, Wong LJ (2010) MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab 99:300–308
Elo JM, Yadavalli SS, Euro L et al (2012) Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet 21:4521–4529
Fassone E, Rahman S (2012) Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet 49:578–590
Filosto M, Scarpelli M, Tonin P et al (2012) Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol 259:2699–2706
Fleming MD (2011) Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation. Hematology Am Soc Hematol Educ Program 2011:525–531
Freisinger P, Futterer N, Lankes E et al (2006) Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol 63:1129–1134
Galmiche L, Serre V, Beinat M et al (2012) Toward genotype phenotype correlations in GFM1 mutations. Mitochondrion 12:242–247
Garone C, Tadesse S, Hirano M (2011) Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 134:3326–3332
Giordano C, Viscomi C, Orlandi M et al (2012) Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis 35:451–458
Goldstein A, Wolfe LA (2013) The elusive magic pill: finding effective therapies for mitochondrial disorders. Neurotherapeutics 10(2):320-8
Goncalves I, Hermans D, Chretien D et al (1995) Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 23:290–294
Hakonen AH, Goffart S, Marjavaara S et al (2008) Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17:3822–3835
Halter J, Schupbach WM, Casali C et al (2011) Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 46:330–337
Harding BN (1990) Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 5:273–287
Hinson JT, Fantin VR, Schonberger J et al (2007) Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. N Engl J Med 356:809
Hirano M, Ricci E, Koenigsberger MR et al (1992) Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 2:125–135
Hirano M, Nishigaki Y, Marti R (2004) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10:8–17
Hirano M, Marti R, Casali C et al (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458–1460
Isohanni P, Hakonen AH, Euro L et al (2011) POLG1 manifestations in childhood. Neurology 76:811–815
Iwama I, Baba Y, Kagimoto S et al (2011) Case report of a successful liver transplantation for acute liver failure due to mitochondrial respiratory chain complex III deficiency. Transplant Proc 43:4025–4028
Kaji S, Murayama K, Nagata I et al (2009) Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II. Mol Genet Metab 97:292–296
Karadimas CL, Vu TH, Holve SA et al (2006) Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 79:544–548
Karkucinska-Wieckowska A, Lebiedzinska M, Jurkiewicz E et al (2011) Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria). Folia Neuropathol 49:56–63
Kayihan N, Nennesmo I, Ericzon BG, Nemeth A (2000) Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage. Pediatr Transplant 4:211–214
Koene S, Rodenburg RJ, van der Knaap MS et al (2012) Natural disease course and genotype-phenotype correlations in complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 35:737–747
Lee WS, Sokol RJ (2007) Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 45:1555–1565
Mancuso M, Ferraris S, Pancrudo J et al (2005) New DGK gene mutations in the hepatocerebral form of mitochondrial DNA depletion syndrome. Arch Neurol 62:745–747
Mandel H, Szargel R, Labay V et al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337–341
Maniura-Weber K, Taylor RW, Johnson MA et al (2004) A novel point mutation in the mitochondrial tRNA(Trp) gene produces a neurogastrointestinal syndrome. Eur J Hum Genet 12:509–512
McShane MA, Hammans SR, Sweeney M et al (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39–42
Moran NF, Bain MD, Muqit MM, Bax BE (2008) Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 71:686–688
Morris EM, Rector RS, Thyfault JP, Ibdah JA (2011) Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal 15:485–504
Mousson de Camaret B, Taanman JW, Padet S et al (2007) Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Biochem J 402:377–385
Mudd SH, Wagner C, Luka Z et al (2012) Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine. Mol Genet Metab 105:228–236
Navarro-Sastre A, Martin-Hernandez E, Campos Y et al (2008) Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. Mol Genet Metab 94:234–239
Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers’ syndrome and mitochondrial DNA depletion. Ann Neurol 55:706–712
Nesbitt V, Pitceathly RD, Turnbull DM et al (2013) The UK MRC Mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A>G mutation–implications for diagnosis and management. J Neurol Neurosurg Psychiatry Jan 25 [Epub ahead of print]
Nobre S, Grazina M, Silva F, Pinto C, Goncalves I, Diogo L (2012) Neonatal liver failure due to deoxyguanosine kinase deficiency. BMJ Case Rep 2012 doi:10.1136/bcr.12.2011.5317
Okamura K, Santa T, Nagae K, Omae T (1976) Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci 27:79–91
Ostergaard E, Christensen E, Kristensen E et al (2007) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383–387
Parini R, Furlan F, Notarangelo L et al (2009) Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. J Hepatol 50:215–221
Pearson HA, Lobel JS, Kocoshis SA et al (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95:976–984
Pitceathly RD, Rahman S, Hanna MG (2012) Single deletions in mitochondrial DNA–molecular mechanisms and disease phenotypes in clinical practice. Neuromuscul Disord 22:577–586
Rahman S (2012) Mitochondrial disease and epilepsy. Dev Med Child Neurol 54:397–406
Rahman S, Hanna MG (2009) Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry 80:943–953
Rahman S, Poulton J (2009) Diagnosis of mitochondrial DNA depletion syndromes. Arch Dis Child 94:3–5
Rahman S, Ecob R, Costello H et al (2012) Hearing in 44–45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study. BMJ Open 2:e000411
Rake JP, Van Spronsen FJ, Visser G et al (2000) End-stage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contra-indication for liver transplantation. Eur J Pediatr 159:523–526
Rivera H, Merinero B, Martinez-Pardo M et al (2010) Marked mitochondrial DNA depletion associated with a novel SUCLG1 gene mutation resulting in lethal neonatal acidosis, multi-organ failure, and interrupted aortic arch. Mitochondrion 10:362–368
Ronchi D, Garone C, Bordoni A et al (2012) Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain 135(Pt 11):3404-15
Rotig A, Colonna M, Bonnefont JP et al (1989) Mitochondrial DNA deletion in Pearson’s marrow/pancreas syndrome. Lancet 1:902–903
Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A (1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4:1327–1330
Sakamoto O, Ohura T, Murayama K et al (2011) Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the SUCLG1 gene. Pediatr Int 53:921–925
Salviati L, Sacconi S, Mancuso M et al (2002) Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 52:311–317
Saneto RP, Lee IC, Koenig MK et al (2010) POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19:140–146
Sarzi E, Goffart S, Serre V et al (2007) Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 62:579–587
Schapira AH (2012) Mitochondrial diseases. Lancet 379:1825–1834
Schara U, Von Kleist-Retzow JC, Lainka E et al (2011) Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J Inherit Metab Dis 34:197–201
Shaibani A, Shchelochkov OA, Zhang S et al (2009) Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 66:1028–1032
Slama A, Giurgea I, Debrey D et al (2005) Deoxyguanosine kinase mutations and combined deficiencies of the mitochondrial respiratory chain in patients with hepatic involvement. Mol Genet Metab 86:462–465
Spiegler J, Stefanova I, Hellenbroich Y, Sperner J (2011) Bowel obstruction in patients with Alpers-Huttenlocher syndrome. Neuropediatrics 42:194–196
Spinazzola A, Viscomi C, Fernandez-Vizarra E et al (2006) MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38:570–575
Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142:133–158
Steenweg ME, Ghezzi D, Haack T et al (2012) Leukoencephalopathy with thalamus and brainstem involvement and high lactate ‘LTBL’ caused by EARS2 mutations. Brain 135:1387–1394
Stiburek L, Vesela K, Hansikova H, Hulkova H, Zeman J (2009) Loss of function of Sco1 and its interaction with cytochrome c oxidase. Am J Physiol Cell Physiol 296:C1218–C1226
Tadiboyina VT, Rupar A, Atkison P et al (2005) Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria. Am J Med Genet A 135:289–291
Talim B, Pyle A, Griffin H et al (2013) Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation. Brain 136:e228
Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D (1998) Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 26:478–481
Thorburn DR (2004) Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis 27:349–362
Thorburn DR, Rahman S (2003) Mitochondrial DNA-associated leigh syndrome and NARP. 2003 Oct 30 [Updated 2011 May 3]. In: Pagon RA, Bird TD, Dolan CR et al (eds) GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1173/
Tiranti V, Zeviani M (2013) Altered sulfide (H2S) metabolism in ethylmalonic encephalopathy. Cold Spring Harb Perspect Biol 5(1):a011437
Tiranti V, D’Adamo P, Briem E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239–252
Tiranti V, Viscomi C, Hildebrandt T et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200–205
Torres-Torronteras J, Gomez A, Eixarch H et al (2011) Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther 18:795–806
Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685–1692
Vafai SB, Mootha VK (2012) Mitochondrial disorders as windows into an ancient organelle. Nature 491:374–383
Valayannopoulos V, Haudry C, Serre V et al (2010) New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria. Mitochondrion 10:335–341
Valnot I, Osmond S, Gigarel N et al (2000) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104–1109
Van Goethem G, Schwartz M, Lofgren A, Dermaut B, Van BC, Vissing J (2003) Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 11:547–549
Van Hove JL, Saenz MS, Thomas JA et al (2010) Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr Res 68:159–164
Verma A, Piccoli DA, Bonilla E, Berry GT, Dimauro S, Moraes CT (1997) A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 42:448–454
Visapaa I, Fellman V, Vesa J et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863–876
Viscomi C, Burlina AB, Dweikat I et al (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16:869–871
Wolf NI, Rahman S, Schmitt B et al (2009) Status epilepticus in children with Alpers’ disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50:1596–1607
Wong LJ, Brunetti-Pierri N, Zhang Q et al (2007) Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 46:1218–1227
Wong LJ, Naviaux RK, Brunetti-Pierri N et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150–E172
Wortmann SB, Vaz FM, Gardeitchik T et al (2012) Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 44:797–802
Zeharia A, Shaag A, Pappo O et al (2009) Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 85:401–407
Acknowledgments
SR is supported by Great Ormond Street Hospital Children’s Charity and receives research grant funding from Ataxia UK, the Child Health Research Appeal Trust, Climb, the Medical Research Council, the Muscular Dystrophy Campaign, Sparks and The Wellcome Trust. David Smithson of UCL Medical Illustration Services provided technical assistance with the artwork.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: John Christodoulou
Rights and permissions
About this article
Cite this article
Rahman, S. Gastrointestinal and hepatic manifestations of mitochondrial disorders. J Inherit Metab Dis 36, 659–673 (2013). https://doi.org/10.1007/s10545-013-9614-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-013-9614-2